Fund Holdings — Enavate Sciences GP, LLC

Total Portfolio Value
$345.38M
Total Bought
$0
Total Sold
$3.43M
Net Transaction
-$3.43M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
ZENAS BIOPHARMA INC(ZBIO)3,919,1593,919,159076,62099,46828.80%+22,849
SIONNA THERAPEUTICS INC(SION)2,478,0302,478,030099,344109,00931.56%+9,664
IMMUNOME INC(IMNM)3,613,7993,613,799079,03476,57622.17%-2,457
CAMP4 THERAPEUTICS CORP(CAMP)2,190,9201,425,541-765,3799,6626,2301.80%-3,432
BRIDGEBIO ONCOLOGY THERAPEUT(BBOT)2,626,9462,626,946023,51120,0175.80%-3,494
UPSTREAM BIO INC(UPB)2,459,7032,459,703022,13717,0214.93%-5,116
COMPASS THERAPEUTICS INC(CMPX)7,788,1507,788,150041,19917,0564.94%-24,143
Page 1 of 1
Enavate Sciences GP, LLC — 13F Holdings — Q2 2026 | TickerTrail